Who owns mutant supplements?
Answers from top 10 papers
More filters
| Papers (10) | Insight |
|---|---|
57 Citations | To that end, a 2010 GAO investigation found that sellers of dietary supplements may actually encourage consumers to substitute supplements for physician-prescribed medications. |
30 Citations | highlight the importance of educating individuals about the FDA's role in regulating dietary supplements. |
23 Citations | Certain populations, includingmilitary personnel, aremore likely to use dietary supplements than the general population. |
| The public's obsession with dietary supplements, despite the inadequacy of evidence demonstrating their benefits, is rather disturbing. | |
| The widespread use of supplements can be viewed as a large, uncontrolled, natural experiment. | |
19 Citations | Another mutant, H25, seems to be a regulatory mutant. |
21 Citations | There are dietary supplements targeting brain health being marketed to consumers that should be considered adulterated and misbranded. |
20 Citations | Patients should be aware of the danger of using adulterated supplements. |
| This indicates that a group of people use supplements as a form of self-medication. | |
37 Citations | Users believed supplements to be effective, although possibly with associated side-effects. |
Related Questions
Who owns gene editing patents?5 answersThe ownership of gene editing patents is currently being disputed between the University of California, Berkeley and the Broad Institute. Both institutions are vying for the rights to the gene-editing system known as CRISPR (clustered regularly interspaced short palindromic repeats). The U.S. Patent Trial and Appeal Board recently ruled in favor of the Broad Institute, allowing them to retain more than a dozen patents related to CRISPR. This decision has raised questions about who can use CRISPR and its future implications for gene editing. The patent disputes in the USA and UK have added complexity to the issue of gene editing ownership. The US Patent and Trademark Office has also been involved in the legal tussle over the rights to genome-editing technology.
Can a cell with a different morphology be considered a mutant?5 answersA cell with a different morphology can be considered a mutant. Tumors, for example, are cyto-structurally abnormal and can be seen as mutant variants of normal parent cells. In the study of phenotypes at a single-cell level, it was found that mutations in genes can lead to distinct mutant phenotypes, including morphological abnormalities. The effect of mutations on individual cell behavior can be studied in genetic mosaics, where the presence of homozygous mutant cells in an otherwise phenotypically wild-type individual can be observed. Additionally, a deep learning model was developed to distinguish cancer cells from normal cells based on their morphology, highlighting the morphological heterogeneity of cancer cells. Changes in morphology and function in cells can be indicative of genetic changes, although determining the genetic character of a change in somatic cells is limited.
How do you get reactor tokens in mutants genetic gladiators?11 answers
How to cheat in mutants genetic gladiators?6 answers
Is mutation required for bank loan?10 answers
Who is the owner of Medline?3 answers